122 related articles for article (PubMed ID: 20458476)
21. [Fluorine-18-2-deoxy-2-fluoro-D-glucose positron emission tomography in colorectal cancer].
Tang G; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Feb; 22(1):193-6, 201. PubMed ID: 15762148
[TBL] [Abstract][Full Text] [Related]
22. Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation.
Prichard RS; Cotter M; Evoy D; Gibbons D; Collins C; McDermott E; Skehan S
Ir Med J; 2011 Jun; 104(6):177-9. PubMed ID: 22111394
[TBL] [Abstract][Full Text] [Related]
23. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies.
Fukuchi K; Ohta H; Matsumura K; Ishida Y
Br J Radiol; 2007 Jan; 80(949):3-11. PubMed ID: 17005513
[TBL] [Abstract][Full Text] [Related]
24. Established, emerging and future roles of PET/CT in the management of colorectal cancer.
Herbertson RA; Scarsbrook AF; Lee ST; Tebbutt N; Scott AM
Clin Radiol; 2009 Mar; 64(3):225-37. PubMed ID: 19185652
[TBL] [Abstract][Full Text] [Related]
25. Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scans.
Hemandas AK; Robson NK; Hickish T; Talbot RW
Colorectal Dis; 2008 May; 10(4):386-9. PubMed ID: 17608754
[TBL] [Abstract][Full Text] [Related]
26. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
27. Incidental focal colonic lesions found on (18)Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management.
Farquharson AL; Chopra A; Ford A; Matthews S; Amin SN; De Noronha R
Colorectal Dis; 2012 Feb; 14(2):e56-63. PubMed ID: 21831171
[TBL] [Abstract][Full Text] [Related]
28. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
[TBL] [Abstract][Full Text] [Related]
29. PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer.
Vikram R; Iyer RB
Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S46-51. PubMed ID: 18852081
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostic strategy of incidental findings of focal thyroid FDG uptake identified on PET/CT].
Nielsen MH; Nygaard B; Søndergaard SB; Bennedbæk FN
Ugeskr Laeger; 2011 Aug; 173(33):1948-52. PubMed ID: 21849133
[TBL] [Abstract][Full Text] [Related]
31. Incidental detection of colorectal cancer via 1(8)F-choline PET/CT in a patient with recurrent prostate cancer: usefulness of early images.
Bagni O; Filippi L; Schillaci O
Clin Nucl Med; 2015 Jun; 40(6):e328-30. PubMed ID: 25674873
[TBL] [Abstract][Full Text] [Related]
32. [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.
Chowdhury FU; Shah N; Scarsbrook AF; Bradley KM
Postgrad Med J; 2010 Mar; 86(1013):174-82. PubMed ID: 20237012
[TBL] [Abstract][Full Text] [Related]
33. A new imaging technique for colorectal cancer: positron emission tomography.
Flamen P; Van Cutsem E; Mortelmans L
Semin Oncol; 2000 Oct; 27(5 Suppl 10):22-9. PubMed ID: 11049029
[No Abstract] [Full Text] [Related]
34. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy.
Liu Y; Ghesani NV; Zuckier LS
Semin Nucl Med; 2010 Jul; 40(4):294-315. PubMed ID: 20513451
[TBL] [Abstract][Full Text] [Related]
35. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
Liu FY; Chen JS; Changchien CR; Yeh CY; Liu SH; Ho KC; Yen TC
Dis Colon Rectum; 2005 Oct; 48(10):1900-12. PubMed ID: 15991059
[TBL] [Abstract][Full Text] [Related]
36. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and risk of malignancy of thyroid incidentalomas detected by (18)f-fluorodeoxyglucose positron-emission tomography.
Treglia G; Giovanella L; Bertagna F; Di Franco D; Salvatori M
Thyroid; 2013 Jan; 23(1):124-6. PubMed ID: 23289835
[No Abstract] [Full Text] [Related]
38. Incidental PET/CT findings in the cancer patient: how should they be managed?
Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
[TBL] [Abstract][Full Text] [Related]
39. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT.
Lim S; Lee EH; Park JM; Chang YW; Kim HH; Jeong SH
Acta Radiol; 2013 Dec; 54(10):1117-24. PubMed ID: 23864064
[TBL] [Abstract][Full Text] [Related]
40. Subcutaneous metastases of colorectal cancer detected with PET/CT.
Karyagar S; Karyagar SS; Kece C; Ozdil B
Clin Nucl Med; 2010 Apr; 35(4):267-8. PubMed ID: 20305419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
